Keyphrases
Glucagon
100%
Visceral Adipose Tissue
61%
Metabolic-associated Fatty Liver Disease (MAFLD)
48%
Hepatic Steatosis
38%
Indirect Mechanism
33%
Liver Fat Content
33%
Older Men
33%
Left-handed
33%
Right-sided
33%
Fibroblast Growth Factor 21 (FGF21)
33%
Colon Resection
33%
Colon Surgery
33%
Obesity
33%
Human pilot
33%
Surgery Effect
33%
Abdominal Obesity
33%
Subcutaneous Adipose Tissue
33%
Prolonged Exercise
33%
Growth Differentiation factor-15 (GDF-15)
33%
Sensitivity Test
33%
Total Adipose Tissue
19%
Tissue Content
14%
Liver Fat
14%
Colon Cancer
14%
Abdominal Adipose Tissue
14%
Agonism
13%
Glucagon Receptor
12%
Type I Diabetes
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Amino Acids
11%
VO2max
11%
Maximal Fat Oxidation
11%
VO 2
11%
Insulin Level
10%
Amino Acid Catabolism
8%
Sensitivity Index
8%
Metabolic Disease
8%
Recreationally Active
7%
Fatmax
7%
Mouse Liver
6%
Insulin
6%
Plasma Parameters
6%
Primary Outcome Measure
5%
Amino Acid Metabolism
5%
Liver-alpha Cell Axis
5%
Biochemistry, Genetics and Molecular Biology
Glucagon
100%
FGF21
33%
Secretion (Process)
33%
Growth Differentiation Factor
33%
Sensitivity Analysis
33%
Amino Acids
22%
Glucagon Receptor
12%
Insulin Level
10%
Blood Level
9%
Mouse
6%
Amino Acid Metabolism
5%
Experimental Test
5%
Medicine and Dentistry
Sensitivity Analysis
33%
Glucagon
33%
Adipose Tissue
33%
Abdominal Obesity
33%
Cancer Surgery
33%
Colon Cancer
33%
Colectomy
33%
Amino Acid
10%
Body Mass Index
7%
Fatty Liver
5%
